Free Trial

GSK (GSK) Earnings Date, Estimates & Call Transcripts

GSK logo
$40.02 +0.84 (+2.13%)
Closing price 05/29/2025 03:59 PM Eastern
Extended Trading
$39.98 -0.03 (-0.08%)
As of 04:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GSK Earnings Summary

GSK announced Q1 2025 earnings on April 30, 2025, reporting an EPS of $1.13, which topped the consensus estimate of $1.08 by $0.05. Quarterly revenue rose 2.1% year-over-year to $10.06 billion, above analysts' expectations of $7.52 billion. With a trailing EPS of $1.94 and a P/E Ratio of 25.17, GSK's earnings are expected to grow 12.32% next year, from $4.14 to $4.65 per share.

Upcoming Q2
Earnings Date
Jul. 30Before Market OpensEstimated
Consensus EPS
(Apr. 30)
$1.08
Actual EPS
(Apr. 30)
$1.13 Beat By $0.05
Actual Revenue
(Apr. 30)
$10.06B

Q1 2025 Earnings Resources

GSK Upcoming Earnings

GSK's next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules.

Get GSK Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GSK and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GSK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GSK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GSK Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20251$1.03$1.03$1.03
Q2 20251$1.08$1.08$1.08
Q3 20251$1.29$1.29$1.29
Q4 20251$0.87$0.87$0.87
FY 2025 4 $4.27 $4.27 $4.27
Q1 20261$1.10$1.10$1.10
Q2 20261$1.13$1.13$1.13
Q3 20261$1.42$1.42$1.42
Q4 20261$1.09$1.09$1.09
FY 2026 4 $4.74 $4.74 $4.74
Q1 20271$1.15$1.15$1.15

GSK Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/30/2025
(Estimated)
--------
4/30/2025Q1 2025$1.08$1.13+$0.05$1.00$7.52B$10.06B
2/5/2025Q4 2024$0.44$0.59+$0.15$0.26$7.75B-
7/31/2024Q2 2024$1.00$1.09+$0.09$1.46$9.49B$9.95B
5/1/2024Q1 2024$0.94$1.09+$0.15$1.53$8.98B$9.34B
1/31/2024Q4 2023$0.76$0.72 -$0.04$1.23$9.79B$10.00B
11/1/2023Q3 2023$1.09$1.26+$0.17$1.62$9.72B$10.32B
7/26/2023Q2 2023$0.85$0.97+$0.12$0.94$8.49B$8.98B

GSK Earnings - Frequently Asked Questions

GSK has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on GSK's earnings history.

GSK issued an update on its FY 2025 earnings guidance on Wednesday, April, 30th. The company provided earnings per share guidance of 4.250-4.590 for the period, compared to the consensus estimate of 4.360. The company issued revenue guidance of $40.7 billion-$42.7 billion, compared to the consensus revenue estimate of $32.6 billion.

In the previous quarter, GSK (NYSE:GSK) reported $1.13 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.05. Learn more on analysts' earnings estimate vs. GSK's actual earnings.

The conference call for GSK's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for GSK's latest earnings report can be read online.
Read Transcript

GSK (NYSE:GSK) has a recorded annual revenue of $31.53 billion.

GSK (NYSE:GSK) has a recorded net income of $3.29 billion. GSK has generated $1.94 earnings per share over the last four quarters.

GSK (NYSE:GSK) has a trailing price-to-earnings ratio of 25.17 and a forward price-to-earnings ratio of 9.67. The price/earnings-to-growth ratio is 1.12.

GSK's earnings are expected to grow from $4.14 per share to $4.65 per share in the next year, which is a 12.32% increase.

More Earnings Resources from MarketBeat



This page (NYSE:GSK) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners